We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Digital Cell Application Assists in Recognition of Blood Cells

By LabMedica International staff writers
Posted on 17 Feb 2011
A new application for digital devices assists in the recognition and classification of blood cells, making it easier for university students and clinical laboratory personnel to learn the basics of cell morphology.

The CellAtlas new application of Apple iPhone and iPod Touch contains mini lectures in English written by experts in hematology. More...
The application gives the technologist access to high-resolution classified cell images complemented by a written description. The CellAtlas reference library provides laboratory personnel with images that can be compared quickly and easily to blood or body fluid cells they are viewing at a microscope.

CellaVision (Lund, Sweden), which develops and sells products for the routine analysis of blood and body fluids, introduced the new application for the Apple iPhone and iPod Touch devices to compliment its digital cell morphology portfolio.

CellQuiz is included in the application to test the user's knowledge in cell morphology. Additionally, the user will have access to links and media that will show how CellaVision systems and software can replace manual microscopy in the hematology lab by saving labor and improving quality.

"It is a pleasure to be able to present the clinical laboratory market with a CellaVision iPhone Application. CellAtlas is an excellent educational tool and reference library for laboratory personnel and students. By making the tool easily accessible we hope to get more laboratories interested in our digital solution for cell analysis,” says Yvonne Mårtensson, CellaVision's CEO.

Related Links:

CellaVision




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.